長期休薬の後に発症したプロピルチオウラシル誘発性ANCA関連血管炎の一例
Here, we report a case of myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPOANCA)-related vasculitis. The patient had been treated with propylthiouracil for Basedow’s disease. Propylthiouracil administration was ceased 20 years ago following thyroid surgery. A 46-year-old woman with a...
Saved in:
| Published in | 臨床リウマチ Vol. 22; no. 2; pp. 236 - 242 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | Japanese |
| Published |
一般社団法人 日本臨床リウマチ学会
2010
The Japanese Society for Clinical Rheumatology and Related Research |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0914-8760 2189-0595 |
| DOI | 10.14961/cra.22.236 |
Cover
| Abstract | Here, we report a case of myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPOANCA)-related vasculitis. The patient had been treated with propylthiouracil for Basedow’s disease. Propylthiouracil administration was ceased 20 years ago following thyroid surgery.
A 46-year-old woman with a 26-year history of Basedow’s disease and 12-year history of rheumatoid arthritis was admitted with high fever and pulmonary hemorrhage. Results of laboratory evaluation were: CRP 7.54 mg/dL, Cr 4.54 mg/dL, Hb 6.8 g/dL.
A diagnosis of MPO-ANCA-associated vasculitis was strongly suggested by positivity for MPO-ANCA (352EU), pulmonary hemorrhage, acute nephritis, and scattered purpura on the limbs. However patient condition did not allow histological confirmation of the diagnosis.
She was treated with methylprednisolone pulse therapy and prednisolone. Consolidation on chest X-ray and C-reactive protein levels improved rapidly. However, pulmonary hemorrhage was repeated four times with tapering of prednisolone. The titer of MPO-ANCA showed a linear decrease during the clinical course. The recurrence of pulmonary hemorrhage was correlated with the level of CRP.
MPO-ANCA-associated vasculitis was caused by propylthiouracil. It was reported that serum ANCA may still remain positive in the majority of patients with propylthiouracil-induced MPO-ANCA positive for up to 5 years. This patient developed MPO-ANCA-associated vasculitis from taking propylthiouracil 20 years previously. ANCA was detected in more than 20% of patients treated with propylthiouracil, but only 6.5% of patients showed clinical evidence of vasculitis. Long-term follow-up may be necessary after discontinuation of propylthiouracil.
Basedow氏病に対して甲状腺亜全摘を受けるまでの間プロピルチオウラシル(PTU)内服治療を受け,20年前に内服終了となった46歳の女性が,喀血を主訴に紹介された.気管から泡沫状血清分泌物が吸引され,MPO-ANCA 352EUなどからANCA関連血管炎に起因する肺胞出血と診断.mPSLパルス療法などで加療した.本症例は内服終了長期を経て発症したPTUに起因するANCA関連血管炎と考えられた. |
|---|---|
| AbstractList | Basedow氏病に対して甲状腺亜全摘を受けるまでの間プロピルチオウラシル(PTU)内服治療を受け,20年前に内服終了となった46歳の女性が,喀血を主訴に紹介された.気管から泡沫状血清分泌物が吸引され,MPO-ANCA 352EUなどからANCA関連血管炎に起因する肺胞出血と診断.mPSLパルス療法などで加療した.本症例は内服終了長期を経て発症したPTUに起因するANCA関連血管炎と考えられた. Here, we report a case of myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPOANCA)-related vasculitis. The patient had been treated with propylthiouracil for Basedow’s disease. Propylthiouracil administration was ceased 20 years ago following thyroid surgery. A 46-year-old woman with a 26-year history of Basedow’s disease and 12-year history of rheumatoid arthritis was admitted with high fever and pulmonary hemorrhage. Results of laboratory evaluation were: CRP 7.54 mg/dL, Cr 4.54 mg/dL, Hb 6.8 g/dL. A diagnosis of MPO-ANCA-associated vasculitis was strongly suggested by positivity for MPO-ANCA (352EU), pulmonary hemorrhage, acute nephritis, and scattered purpura on the limbs. However patient condition did not allow histological confirmation of the diagnosis. She was treated with methylprednisolone pulse therapy and prednisolone. Consolidation on chest X-ray and C-reactive protein levels improved rapidly. However, pulmonary hemorrhage was repeated four times with tapering of prednisolone. The titer of MPO-ANCA showed a linear decrease during the clinical course. The recurrence of pulmonary hemorrhage was correlated with the level of CRP. MPO-ANCA-associated vasculitis was caused by propylthiouracil. It was reported that serum ANCA may still remain positive in the majority of patients with propylthiouracil-induced MPO-ANCA positive for up to 5 years. This patient developed MPO-ANCA-associated vasculitis from taking propylthiouracil 20 years previously. ANCA was detected in more than 20% of patients treated with propylthiouracil, but only 6.5% of patients showed clinical evidence of vasculitis. Long-term follow-up may be necessary after discontinuation of propylthiouracil. Basedow氏病に対して甲状腺亜全摘を受けるまでの間プロピルチオウラシル(PTU)内服治療を受け,20年前に内服終了となった46歳の女性が,喀血を主訴に紹介された.気管から泡沫状血清分泌物が吸引され,MPO-ANCA 352EUなどからANCA関連血管炎に起因する肺胞出血と診断.mPSLパルス療法などで加療した.本症例は内服終了長期を経て発症したPTUに起因するANCA関連血管炎と考えられた. |
| Author | 真鍋, 和代 安室, 秀樹 澤井, 宏和 福原, 資郎 嶋元, 佳子 尾崎, 吉郎 木畑, 佳代子 伊藤, 量基 孫, 瑛洙 和田, 孝彦 田中, 晶大 |
| Author_FL | Manabe Kazuyo 尾崎 吉郎 Ito Tomoki 木畑 佳代子 Shimamoto Keiko Amuro Hideki Wada Takahiko 田中 晶大 孫 瑛洙 Sawai Hirokazu Fukuhara Shirou |
| Author_FL_xml | – sequence: 1 fullname: 尾崎 吉郎 – sequence: 2 fullname: Manabe Kazuyo – sequence: 3 fullname: 木畑 佳代子 – sequence: 4 fullname: 田中 晶大 – sequence: 5 fullname: Shimamoto Keiko – sequence: 6 fullname: Amuro Hideki – sequence: 7 fullname: 孫 瑛洙 – sequence: 8 fullname: Sawai Hirokazu – sequence: 9 fullname: Ito Tomoki – sequence: 10 fullname: Wada Takahiko – sequence: 11 fullname: Fukuhara Shirou |
| Author_xml | – sequence: 1 fullname: 孫, 瑛洙 organization: 関西医科大学附属枚方病院リウマチ・膠原病科 – sequence: 1 fullname: 伊藤, 量基 organization: 関西医科大学内科学第一講座 – sequence: 1 fullname: 和田, 孝彦 organization: 関西医科大学附属枚方病院リウマチ・膠原病科 – sequence: 1 fullname: 木畑, 佳代子 organization: 関西医科大学内科学第一講座 – sequence: 1 fullname: 嶋元, 佳子 organization: 関西医科大学内科学第一講座 – sequence: 1 fullname: 真鍋, 和代 organization: 関西医科大学附属枚方病院リウマチ・膠原病科 – sequence: 1 fullname: 安室, 秀樹 organization: 関西医科大学内科学第一講座 – sequence: 1 fullname: 田中, 晶大 organization: 関西医科大学附属枚方病院リウマチ・膠原病科 – sequence: 1 fullname: 澤井, 宏和 organization: 関西医科大学附属枚方病院リウマチ・膠原病科 – sequence: 1 fullname: 尾崎, 吉郎 organization: 関西医科大学附属枚方病院リウマチ・膠原病科 – sequence: 1 fullname: 福原, 資郎 organization: 関西医科大学内科学第一講座 |
| BackLink | https://cir.nii.ac.jp/crid/1390001204341192448$$DView record in CiNii |
| BookMark | eNpFkEtLAlEAhS9hkJmr_kLbsfua8d5FC5FeILWp9TAz906NmMXopt08Fi2KICgtCMSCIi23RoR_5pqPf9GUQZtz4PBx4JxFkKoeVyUAywjmEOUGWnV8K4dxDhNjDqQxYlyDOtdTIA05ohrLG3ABZGs1z4aQQog4w2kgpjf90X1r-Hk1abyqsPc1uFBhd3z3MW6eqbCpwpaKmyp-U_G1irsqDlXUUdGTil9U1E-SSec2gUfBc2GnWJg2HqbB46QdjHvtcXSZ1A3fg-HgfAnMu1alJrN_ngH7G-t7xS2ttLu5XSyUtDImkGk6g7bDpUGx0CHNS064FEjozEZ5JqFjuYLanLmQ2szVqURCukJCHRFbCIkRyYCVWW_V80zH-1FEOEy2YkgJRYhjSlmCrc2wcq1uHUjzxPeOLP_UtPy651SkmfxoYmziXyHGf35o-WbZIt_74Y4C |
| ContentType | Journal Article |
| Copyright | 2010 一般社団法人日本臨床リウマチ学会 |
| Copyright_xml | – notice: 2010 一般社団法人日本臨床リウマチ学会 |
| DBID | RYH |
| DOI | 10.14961/cra.22.236 |
| DatabaseName | CiNii Complete |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | Anti-neutrophil cytoplasmic antibody-associated vasculitis after long-term interruption of propylthiouracil therapy |
| DocumentTitle_FL | Anti-neutrophil cytoplasmic antibody-associated vasculitis after long-term interruption of propylthiouracil therapy |
| EISSN | 2189-0595 |
| EndPage | 242 |
| ExternalDocumentID | 130005127455 article_cra_22_2_22_236_article_char_ja |
| GroupedDBID | ALMA_UNASSIGNED_HOLDINGS JSF KQ8 RJT RYH |
| ID | FETCH-LOGICAL-j2308-580bc9e642d5047e939ed1d58b178e0cafd4b98f04b8f54e1defde0513bdde213 |
| ISSN | 0914-8760 |
| IngestDate | Thu Jun 26 23:42:58 EDT 2025 Wed Sep 03 06:01:12 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 2 |
| Language | Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j2308-580bc9e642d5047e939ed1d58b178e0cafd4b98f04b8f54e1defde0513bdde213 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/cra/22/2/22_236/_article/-char/ja |
| PageCount | 7 |
| ParticipantIDs | nii_cinii_1390001204341192448 jstage_primary_article_cra_22_2_22_236_article_char_ja |
| PublicationCentury | 2000 |
| PublicationDate | 2010 |
| PublicationDateYYYYMMDD | 2010-01-01 |
| PublicationDate_xml | – year: 2010 text: 2010 |
| PublicationDecade | 2010 |
| PublicationTitle | 臨床リウマチ |
| PublicationTitleAlternate | 臨床リウマチ |
| PublicationTitle_FL | Clinical Rheumatology and Related Research 臨床リウマチ |
| PublicationYear | 2010 |
| Publisher | 一般社団法人 日本臨床リウマチ学会 The Japanese Society for Clinical Rheumatology and Related Research |
| Publisher_xml | – name: 一般社団法人 日本臨床リウマチ学会 – name: The Japanese Society for Clinical Rheumatology and Related Research |
| References | 7) Gao, Y., Zhao, M.H.: Drug-induced antineutrophil cytoplasmic antibodyassociated vasculitis. Nephrol., 14: 33-41, 2009. 4) Dolman, K.M., Gans, R.O., Vervaat, T.J., et al.: Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylyhiouracil therapy. Lancet, 342: 651-652, 1993. 5) Fujieda, M., Hattori, M., Kurayama, H., et al.: Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J. Am. Soc. Nephrol., 13: 437-445, 2002. 13) Ohtsuka, M., Yamashita, Y., Doi, M., et al.: Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody. Eur. Respir. J., 10: 1405-1407, 1997. 16) Stankus, S.J., Johnson, N.T.: Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest, 102: 1595-1596, 1992. 2) Brimness, J., Halberg, P., Jacobsen, S., et al.: Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA). Clin. Exp. Immunol., 110: 250-256, 1997. 14) Sato, H., Hattori, M., Fujieda, M., et al.: High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves’ disease treated with propylthiouracil. J. Clin. Endocrinol. Metab., 85: 4270-4273, 2000. 17) Vittecoq, O., Jouen-Beades, F., Kezanowska, K., et al.: Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis. Rheumatology (Oxford), 39:481-489, 2000. 1) Amrhein, J.A., Kenny, M., Ross, D.: Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. J. Pediatr., 76: 54-63, 1970. 12) Noh, J.Y., Yasuda, S., Sato, S., et al.: Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J. Clin. Endocrinol. Metab., 94: 2806-2811, 2009. 10) Merkel, P.A.: Drug-induced vasculitis. Rheum. Dis. Clin. North. Am., 27: 849-862, 2001. 3) Chen, Y.X., Yu, H.J., Ni, L.Y., et al.: Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: Retrospective study of 19 cases. J. Rheumatol., 34: 2451-2456, 2007. 11) Noh, J.Y., Asari, T., Hamada, N., et al.: Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves’ disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestation. Clin. Endocrinol. (Oxf.), 54: 651-654, 2001. 8) Geffriaud-Ricouard, C., Noël, L.H., Chauveau, D., et al.: Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin. Nephrol., 39: 125-136, 1993. 6) Gao, Y., Chen, M., Ye, H., et al.: Longterm outcomes of patients with propylthiouracil-induced antineutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatology (Oxford), 47: 1515-1520, 2008. 9) Goto, A., Mukai, M., Notoya, A., et al.: Rheumatoid arthritis complicated with myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: a case report, 15: 118-122, 2005. 15) Sera, N., Ashizawa, K., Ando, T., et al.: Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves’ disease. Thyroid, 10: 595-599, 2000. |
| References_xml | – reference: 2) Brimness, J., Halberg, P., Jacobsen, S., et al.: Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA). Clin. Exp. Immunol., 110: 250-256, 1997. – reference: 5) Fujieda, M., Hattori, M., Kurayama, H., et al.: Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J. Am. Soc. Nephrol., 13: 437-445, 2002. – reference: 14) Sato, H., Hattori, M., Fujieda, M., et al.: High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves’ disease treated with propylthiouracil. J. Clin. Endocrinol. Metab., 85: 4270-4273, 2000. – reference: 15) Sera, N., Ashizawa, K., Ando, T., et al.: Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves’ disease. Thyroid, 10: 595-599, 2000. – reference: 16) Stankus, S.J., Johnson, N.T.: Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest, 102: 1595-1596, 1992. – reference: 8) Geffriaud-Ricouard, C., Noël, L.H., Chauveau, D., et al.: Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin. Nephrol., 39: 125-136, 1993. – reference: 6) Gao, Y., Chen, M., Ye, H., et al.: Longterm outcomes of patients with propylthiouracil-induced antineutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatology (Oxford), 47: 1515-1520, 2008. – reference: 17) Vittecoq, O., Jouen-Beades, F., Kezanowska, K., et al.: Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis. Rheumatology (Oxford), 39:481-489, 2000. – reference: 10) Merkel, P.A.: Drug-induced vasculitis. Rheum. Dis. Clin. North. Am., 27: 849-862, 2001. – reference: 12) Noh, J.Y., Yasuda, S., Sato, S., et al.: Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J. Clin. Endocrinol. Metab., 94: 2806-2811, 2009. – reference: 7) Gao, Y., Zhao, M.H.: Drug-induced antineutrophil cytoplasmic antibodyassociated vasculitis. Nephrol., 14: 33-41, 2009. – reference: 9) Goto, A., Mukai, M., Notoya, A., et al.: Rheumatoid arthritis complicated with myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: a case report, 15: 118-122, 2005. – reference: 1) Amrhein, J.A., Kenny, M., Ross, D.: Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. J. Pediatr., 76: 54-63, 1970. – reference: 4) Dolman, K.M., Gans, R.O., Vervaat, T.J., et al.: Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylyhiouracil therapy. Lancet, 342: 651-652, 1993. – reference: 11) Noh, J.Y., Asari, T., Hamada, N., et al.: Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves’ disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestation. Clin. Endocrinol. (Oxf.), 54: 651-654, 2001. – reference: 3) Chen, Y.X., Yu, H.J., Ni, L.Y., et al.: Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: Retrospective study of 19 cases. J. Rheumatol., 34: 2451-2456, 2007. – reference: 13) Ohtsuka, M., Yamashita, Y., Doi, M., et al.: Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody. Eur. Respir. J., 10: 1405-1407, 1997. |
| SSID | ssib004001982 ssj0003304618 ssib029852172 ssib058494229 |
| Score | 1.8118515 |
| Snippet | Basedow氏病に対して甲状腺亜全摘を受けるまでの間プロピルチオウラシル(PTU)内服治療を受け,20年前に内服終了となった46歳の女性が,喀血を主訴に紹介された.気... Here, we report a case of myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPOANCA)-related vasculitis. The patient had been treated with... |
| SourceID | nii jstage |
| SourceType | Publisher |
| StartPage | 236 |
| SubjectTerms | adverse effects antineutrophil cytoplasmic antibodies propylthiouracil rheumatoid arthritis |
| Title | 長期休薬の後に発症したプロピルチオウラシル誘発性ANCA関連血管炎の一例 |
| URI | https://www.jstage.jst.go.jp/article/cra/22/2/22_236/_article/-char/ja https://cir.nii.ac.jp/crid/1390001204341192448 |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 臨床リウマチ, 2010/06/30, Vol.22(2), pp.236-242 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2189-0595 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0003304618 issn: 0914-8760 databaseCode: KQ8 dateStart: 20080101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9RAFA-1XryIomLVSg_OSbYmk8lk5jjZZimCBaGF4iXkE7uHKqW9eNqPgwdFELRVEEoVFFvttSLSfya12_4XvjdJdiP1UAvL8Pbtb968j0nmzexkYhh3MshyKY-thhO7ZoOFWdgQ3I4bWcKdiEkeJfrvggdzfHaB3V90FsfGH9V2La2tRtPxs38-V3KWqAIP4opPyf5HZIdCgQE0xBdKiDCUp4ox8SWRDvFc4nMim0S2iM-IB4RFfEEkJ6pJfBuyRaJ84gPSJ2LI8YjvEimJpzThEuGWP8kh0dKEXXFsomYqDqs4XkkAHglKlKoIXmFkyfHcWi2BSClqanDceKFcNddU2jYwgCKBXFtXsJCGCmAP0ECAUOHXjAT7hcYwba1Xz75RAhiphPaFIkJV2pzQWPpDq6o-iZXAfNAcuqVWGhzkodIeI1KOYDoEKFug3xQr8BKbFi2UAm4drY9oBtVxcdGrnlngdWNyRqsKrfIRXsdaFX5zUAuNZwjzbE142l2FBLO-sFNu7sWLsOYqKIXuKlpbT3cVWcjgKBJaQbCCz13dPOCcSo_m2bxaeZNXXVbVV40thgNooWyqeZAkygZk6U59UKW0dvOg9RHS5rVkixZHq50Yx-EugQN5vBJOUzo9rPPXwejlZRcAKKA0oLqweTDkPw5XgjbMnc5TXKvDDRsPRX3ssuToXCcqhYPvaqu-Q14uGS2nDpjV2frVBDqxq3xQPu6Lut4baQqpbBsmdnhix7nlpaVatjp_ybhYTjOnVKHkZWOsHV4xkuO3e4cfNg9-vT5a_5Z3d3_vv8y7O4P3Pwcbz_PuRt7dzPsbef973n-T93fyfjfvbee9z3n_a97bA87R9jsAH3a-4PV5vP7xuPPpaKsz2N0a9F6BuIMfnYP9F1eNhZY_35xtlG9ZabSpbeJjl2YUy5Qzmjgmc1NpyzSxEkdElitSMw6zhEVSZCaLROaw1ErSLElhLLcjSI2oZV8zxpefLKfXjanEzASFO73JwoTRKBZmaJkpT5ljc2nKdMLghWuCp8VROsEpYzhhTIIrg3gJS5iz6vVzk0EGjutHTNw4q-CbxoViOxCuqd4yxldX1tJJmGWsRrd1d_kDnvbt4g |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E9%95%B7%E6%9C%9F%E4%BC%91%E8%96%AC%E3%81%AE%E5%BE%8C%E3%81%AB%E7%99%BA%E7%97%87%E3%81%97%E3%81%9F%E3%83%97%E3%83%AD%E3%83%94%E3%83%AB%E3%83%81%E3%82%AA%E3%82%A6%E3%83%A9%E3%82%B7%E3%83%AB%E8%AA%98%E7%99%BA%E6%80%A7ANCA%E9%96%A2%E9%80%A3%E8%A1%80%E7%AE%A1%E7%82%8E%E3%81%AE%E4%B8%80%E4%BE%8B&rft.jtitle=%E8%87%A8%E5%BA%8A%E3%83%AA%E3%82%A6%E3%83%9E%E3%83%81&rft.au=%E5%AD%AB%2C+%E7%91%9B%E6%B4%99&rft.au=%E4%BC%8A%E8%97%A4%2C+%E9%87%8F%E5%9F%BA&rft.au=%E5%92%8C%E7%94%B0%2C+%E5%AD%9D%E5%BD%A6&rft.au=%E6%9C%A8%E7%95%91%2C+%E4%BD%B3%E4%BB%A3%E5%AD%90&rft.date=2010&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E8%87%A8%E5%BA%8A%E3%83%AA%E3%82%A6%E3%83%9E%E3%83%81%E5%AD%A6%E4%BC%9A&rft.issn=0914-8760&rft.eissn=2189-0595&rft.volume=22&rft.issue=2&rft.spage=236&rft.epage=242&rft_id=info:doi/10.14961%2Fcra.22.236&rft.externalDocID=article_cra_22_2_22_236_article_char_ja |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0914-8760&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0914-8760&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0914-8760&client=summon |